Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Sherman

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2012
A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancerMatthew G Fury, Eric Sherman, Donna Lisa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2022
Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404)Alan L Ho, Nathan R Foster, Alex J Zoroufy, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2016
Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal CarcinomaNancy Lee, Heiko Schoder, Brad Beattie, et al.
International Journal of Radiation Oncology, Biology, Physics|May 24, 2011
Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastasesAmita Shukla-Dave, Nancy Y Lee, Jacobus F A Jansen, et al.
Head & Neck|September 29, 2021
The effect of short radiation treatment breaks on chemo-radiotherapy for oropharyngeal cancersAlisa Rybkin, Jung Julie Kang, Anna Lee, et al.
Ophthalmology|September 14, 2023
Relationship between Unstable Housing, Food Insecurity, and Vision Status in the MI-SIGHT Community Eye Disease Screening ProgramMikaelah A Johnson-Griggs, Patrice M Hicks, Ming-Chen Lu, et al.
Molecular Therapy. Methods & Clinical Development|March 28, 2017
INSPIIRED: A Pipeline for Quantitative Analysis of Sites of New DNA Integration in Cellular GenomesEric Sherman, Christopher Nobles, Charles C Berry, et al.
International Journal of Particle Therapy|February 2, 2026
The Use of Protons in the Management of Recurrent, Previously Irradiated Adenoid Cystic CarcinomaIrini Yacoub, Achraf Shamseddine, Daniel Kallini, et al.
International Journal of Particle Therapy|October 29, 2025
The Use of Proton Radiation in the Management of Adenoid Cystic CarcinomaIrini Yacoub, Achraf Shamseddine, Daniel Kallini, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2025
Apparent Diffusion Coefficient Magnetic Resonance Imaging as a Predictive Biomarker for Hypoxia, Treatment De-escalation, and Recurrence in Human Papillomavirus-Associated Oropharyngeal CancerJames E Han, Bill H Diplas, Ramesh Paudyal, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2012
A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancerMatthew G Fury, Eric Sherman, Donna Lisa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2022
Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404)Alan L Ho, Nathan R Foster, Alex J Zoroufy, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2016
Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal CarcinomaNancy Lee, Heiko Schoder, Brad Beattie, et al.
International Journal of Radiation Oncology, Biology, Physics|May 24, 2011
Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastasesAmita Shukla-Dave, Nancy Y Lee, Jacobus F A Jansen, et al.
Head & Neck|September 29, 2021
The effect of short radiation treatment breaks on chemo-radiotherapy for oropharyngeal cancersAlisa Rybkin, Jung Julie Kang, Anna Lee, et al.
Ophthalmology|September 14, 2023
Relationship between Unstable Housing, Food Insecurity, and Vision Status in the MI-SIGHT Community Eye Disease Screening ProgramMikaelah A Johnson-Griggs, Patrice M Hicks, Ming-Chen Lu, et al.
Molecular Therapy. Methods & Clinical Development|March 28, 2017
INSPIIRED: A Pipeline for Quantitative Analysis of Sites of New DNA Integration in Cellular GenomesEric Sherman, Christopher Nobles, Charles C Berry, et al.
International Journal of Particle Therapy|February 2, 2026
The Use of Protons in the Management of Recurrent, Previously Irradiated Adenoid Cystic CarcinomaIrini Yacoub, Achraf Shamseddine, Daniel Kallini, et al.
International Journal of Particle Therapy|October 29, 2025
The Use of Proton Radiation in the Management of Adenoid Cystic CarcinomaIrini Yacoub, Achraf Shamseddine, Daniel Kallini, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2025
Apparent Diffusion Coefficient Magnetic Resonance Imaging as a Predictive Biomarker for Hypoxia, Treatment De-escalation, and Recurrence in Human Papillomavirus-Associated Oropharyngeal CancerJames E Han, Bill H Diplas, Ramesh Paudyal, et al.
Pageof 10